Athersys, Inc.(NASDAQ : ATHX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||-0.96%||724.85||2.6%||$747.47m|
|GILD||Gilead Sciences, Inc.||-0.11%||64.88||1.0%||$549.46m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.08%||298.38||1.9%||$429.56m|
|SNSS||Sunesis Pharmaceuticals, Inc.||0.75%||4.05||0.7%||$283.11m|
|SAVA||Cassava Sciences, Inc.||-5.17%||40.16||0.0%||$179.87m|
|BMRN||BioMarin Pharmaceutical, Inc.||-3.14%||88.61||4.2%||$92.91m|
|PRTA||Prothena Corp. Plc||-2.55%||57.08||13.8%||$77.20m|
|CRSP||CRISPR Therapeutics AG||-4.04%||62.63||0.6%||$75.07m|
Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.